Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indication that causes inflammation and sores in the inner lining of colon and rectum. Crohn’s disease is part of inflammatory bowel disease that causes inflammation to any part of gastrointestinal tract, right from mouth to small intestine and anus. The exact cause of inflammatory bowel diseases is not known; however, autoimmune disorders, genetic factors, and lifestyle changes are thought to cause the symptoms of inflammatory bowel diseases in an individual mon symptoms of inflammatory bowel diseases include diarrhea, abdominal pain & cramps, constipation, rectal bleeding, weight loss, and fever. Inflammatory bowel diseases (IBD) affect men and women equally and is more commonly observed in developed countries in the West than developing and underdeveloped countries. There is no single test that can diagnose the inflammatory bowel disease. However, the laboratory tests primarily involve blood test, fecal test, and genetic test. The laboratory tests are performed in conjunction with other screening tests such as CT-Scan, colonoscopy, endoscopy, and MRI screening.
Highlights
The global In-vitro Inflammatory Bowel Disease Diagnostic market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for In-vitro Inflammatory Bowel Disease Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for In-vitro Inflammatory Bowel Disease Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for In-vitro Inflammatory Bowel Disease Diagnostic in Diagnostic Laboratories is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of In-vitro Inflammatory Bowel Disease Diagnostic include DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott, Quidel Corporation, American Laboratory Products Company (ALPCO), Certest Biotec SL. and Biosystems S.A., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In-vitro Inflammatory Bowel Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Inflammatory Bowel Disease Diagnostic.
The In-vitro Inflammatory Bowel Disease Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In-vitro Inflammatory Bowel Disease Diagnostic market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-vitro Inflammatory Bowel Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott
Quidel Corporation
American Laboratory Products Company (ALPCO)
Certest Biotec SL.
Biosystems S.A.
Segment by Type
Assays/Biomarker
Analyzers
Segment by Application
Diagnostic Laboratories
Hospitals
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-vitro Inflammatory Bowel Disease Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Assays/Biomarker
1.2.3 Analyzers
1.3 Market by Application
1.3.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Perspective (2018-2029)
2.2 In-vitro Inflammatory Bowel Disease Diagnostic Growth Trends by Region
2.2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Region (2024-2029)
2.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Dynamics
2.3.1 In-vitro Inflammatory Bowel Disease Diagnostic Industry Trends
2.3.2 In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers
2.3.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Challenges
2.3.4 In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue
3.1.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue (2018-2023)
3.1.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-vitro Inflammatory Bowel Disease Diagnostic Revenue
3.4 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio
3.4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2022
3.5 In-vitro Inflammatory Bowel Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players In-vitro Inflammatory Bowel Disease Diagnostic Product Solution and Service
3.7 Date of Enter into In-vitro Inflammatory Bowel Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Type
4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Type (2024-2029)
5 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Application
5.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2018-2029)
6.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2018-2023)
6.4 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2018-2029)
7.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2018-2023)
7.4 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2018-2029)
8.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2018-2029)
9.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2018-2023)
9.4 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2018-2029)
10.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DiaSorin S.p.A
11.1.1 DiaSorin S.p.A Company Detail
11.1.2 DiaSorin S.p.A Business Overview
11.1.3 DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.1.4 DiaSorin S.p.A Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.1.5 DiaSorin S.p.A Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Detail
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Siemens Healthineers AG
11.3.1 Siemens Healthineers AG Company Detail
11.3.2 Siemens Healthineers AG Business Overview
11.3.3 Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.3.4 Siemens Healthineers AG Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.3.5 Siemens Healthineers AG Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.4.4 Abbott Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.4.5 Abbott Recent Development
11.5 Quidel Corporation
11.5.1 Quidel Corporation Company Detail
11.5.2 Quidel Corporation Business Overview
11.5.3 Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.5.4 Quidel Corporation Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.5.5 Quidel Corporation Recent Development
11.6 American Laboratory Products Company (ALPCO)
11.6.1 American Laboratory Products Company (ALPCO) Company Detail
11.6.2 American Laboratory Products Company (ALPCO) Business Overview
11.6.3 American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.6.4 American Laboratory Products Company (ALPCO) Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.6.5 American Laboratory Products Company (ALPCO) Recent Development
11.7 Certest Biotec SL.
11.7.1 Certest Biotec SL. Company Detail
11.7.2 Certest Biotec SL. Business Overview
11.7.3 Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.7.4 Certest Biotec SL. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.7.5 Certest Biotec SL. Recent Development
11.8 Biosystems S.A.
11.8.1 Biosystems S.A. Company Detail
11.8.2 Biosystems S.A. Business Overview
11.8.3 Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.8.4 Biosystems S.A. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.8.5 Biosystems S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott
Quidel Corporation
American Laboratory Products Company (ALPCO)
Certest Biotec SL.
Biosystems S.A.
Ěý
Ěý
*If Applicable.
